<?xml version="1.0" encoding="iso-8859-1"?> 
				<rss version="2.0"> 
				<channel> 
					<title>Latest Medical/Research News and Press Release – Free Medical/Research RSS @ 1888 Press Release.com</title> 
					<link>http://www.1888pressrelease.com</link> 
					<description>Free Medical/Research RSS. Subscribe to latest Medical/Research News and press releases @ 1888 PressRelease.Com.</description> 
					<copyright>(c) 2005-2013, 1888 Press Release.com. All rights reserved.</copyright><item>
								<title>Dr. Sanjay Gupta, CNN Chief Medical Correspondent, to Deliver Keynote Speech at Traumatic Brain Injury Conference: Changing the Game - Jacksonville, Florida</title>
								<link>http://www.1888pressrelease.com/dr-sanjay-gupta-cnn-chief-medical-correspondent-to-delive-pr-471357.html</link> 
								<description>The Toral Family Foundation Gears up to Provide Florida Clinicians a Comprehensive One-Day Program on Traumatic Brain Injuries (TBI).</description>				
								<pubDate>Thu, 16 May 2013 00:00:00 GMT</pubDate>
							</item><item>
								<title>Vascular BioSciences Publishes -Vascular Histomolecular Analysis By Sequential Endoarterial Biopsy in a Shunt Model of Pulmonary Hypertension- in the Current Pulmonary Circulation</title>
								<link>http://www.1888pressrelease.com/vascular-biosciences-publishes-vascular-histomolecular-anal-pr-465437.html</link> 
								<description>Vascular BioSciences announces the publication of -Vascular Histomolecular Analysis By Sequential Endoarterial Biopsy in a Shunt Model of Pulmonary Hypertension- to the current issue of the Pulmonary Circulation, Volume 3, Number 1, January to March 2013. Details how percutaneous pulmonary endoarterial biopsy coupled with histologic and molecular analysis represents a potential model of diagnosis.</description>				
								<pubDate>Thu, 11 Apr 2013 00:00:00 GMT</pubDate>
							</item><item>
								<title>Lupus Clinical Trial Now Enrolling at Achieve Clinical Research in Birmingham, Alabama; Accepting African-American M/F Age 18+ with Systemic Lupus Erythematosus (SLE)</title>
								<link>http://www.1888pressrelease.com/lupus-clinical-trial-now-enrolling-at-achieve-clinical-resea-pr-462971.html</link> 
								<description>A Phase 3/4, Multi-Center, Randomized, Double-Blind, Placebo Controlled, 52-Week Study to Evaluate the Efficacy and Safety of Belimumab (HGS1006) in Adult Subjects of Black Race with Systemic Lupus Erythematosus (SLE).</description>				
								<pubDate>Thu, 28 Mar 2013 00:00:00 GMT</pubDate>
							</item><item>
								<title>Smallpox Vaccine Clinical Study Now Enrolling at Avail Clinical Research near Orlando, Florida; Accepting Healthy M/F Age 18-40</title>
								<link>http://www.1888pressrelease.com/smallpox-vaccine-clinical-study-now-enrolling-at-avail-clini-pr-463114.html</link> 
								<description>A randomized, double-blind, placebo-controlled Phase III Trial to evaluate immunogenicity and safety of three consecutive production lots of the IMVAMUNE® smallpox vaccine in healthy subjects.</description>				
								<pubDate>Thu, 28 Mar 2013 00:00:00 GMT</pubDate>
							</item><item>
								<title>HealthCarePoint completes the integration of transnational collaborative platform for healthcare and clinical research</title>
								<link>http://www.1888pressrelease.com/healthcarepoint-completes-the-integration-of-transnational-c-pr-447791.html</link> 
								<description>Streamlining HealthCare and Clinical Research.</description>				
								<pubDate>Mon, 07 Jan 2013 00:00:00 GMT</pubDate>
							</item><item>
								<title>New Phase 3 Paid Meningitis Clinical Trial Now Enrolling at Avail Clinical Research near Orlando Florida; Accepting Male and Female Participants</title>
								<link>http://www.1888pressrelease.com/new-phase-3-paid-meningitis-clinical-trial-now-enrolling-at-pr-445283.html</link> 
								<description>This study is a Phase 3, Randomized, Placebo-Controlled, Double-Blind Trial to Assess the Safety, Tolerability and Immunogenicity of a new Meningococcal Vaccine When Given in Healthy Subjects Age 11 to 26.</description>				
								<pubDate>Fri, 21 Dec 2012 00:00:00 GMT</pubDate>
							</item><item>
								<title>Editage, the leading English editing and publication support provider, partners with Publishers' Desk</title>
								<link>http://www.1888pressrelease.com/editage-the-leading-english-editing-and-publication-support-pr-444629.html</link> 
								<description>Partnership between Editage and Publishers' Desk.</description>				
								<pubDate>Wed, 19 Dec 2012 00:00:00 GMT</pubDate>
							</item><item>
								<title>Doctors Holding Free Pre-Clinical Trials for Patients with Invisible Illnesses</title>
								<link>http://www.1888pressrelease.com/doctors-holding-free-pre-clinical-trials-for-patients-with-i-pr-439873.html</link> 
								<description>Dr. Diana Driscoll, President of Genetic Disease Investigators, LLC., in conjunction with Total Eye Care, is beginning FREE pre-clinical trials in search of a cure for -Invisible Illnesses-.  These may include Chronic Fatigue Syndrome, Multiple Sclerosis, Ehlers-Danlos syndrome with Dysautonomia, Rheumatoid Arthritis, Endometriosis, and Chronic Lyme Disease.</description>				
								<pubDate>Wed, 05 Dec 2012 00:00:00 GMT</pubDate>
							</item><item>
								<title>New Paid Lupus Clinical Trial Enrolling at Achieve Clinical Research in Birmingham, AL; Accepting M/F Age 18+ with Positive Systemic Lupus Erythematosus</title>
								<link>http://www.1888pressrelease.com/new-paid-lupus-clinical-trial-enrolling-at-achieve-clinical-pr-440945.html</link> 
								<description>This is a global, multi-center, randomized, placebo-controlled study to evaluate adverse events of special interest in adults with active, autoantibody-positive systemic lupus erythematosus (SLE) treated with a new drug plus standard therapy vs placebo plus standard therapy.</description>				
								<pubDate>Sat, 01 Dec 2012 00:00:00 GMT</pubDate>
							</item>
				</channel>
				</rss>